V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260008423 | 260005647 | null | 60.5 | Curative (C) | null | 2018-02-20 | CHLORAMBUCIL + RITUXIMAB | null | null | 260027885 | RITUXIMAB |
| 260008424 | 260005647 | null | 81.7 | Disease modification (D) | 2015-05-24 | 2015-05-24 | Rituximab | 02 | Y | 260027885 | RITUXIMAB |
| 260008425 | 260005648 | 1.69 | 84 | Disease modification (D) | 2017-02-16 | 2017-03-02 | DHAP - R | 02 | N | 260027889 | BENDAMUSTINE |
| 260008426 | 260005648 | 1.73 | 80.9 | null | null | 2016-03-08 | Rituximab (INTRAVENOUS Maintenance) | 2 | null | 260027889 | BENDAMUSTINE |
| 260008427 | 260005649 | 1.66 | null | Curative (C) | null | 2018-07-25 | GEM-P | N | N | 260027891 | RITUXIMAB |
| 260008428 | 260011915 | 1.8 | 79.2 | null | null | 2016-08-22 | Rituximab | null | null | 260027894 | RITUXIMAB |
| 260008429 | 260005650 | 1.61 | null | Palliative (P) | 2013-04-14 | 2013-04-15 | FEC 60 or 75 | N | N | 260027900 | RITUXIMAB |
| 260008430 | 260011916 | 1.78 | 84.1 | Neo-adjuvant (N) | 2013-02-05 | 2013-03-06 | FCR | N | N | 260027901 | NILOTINIB |
| 260008431 | 260005651 | null | null | Palliative (P) | null | 2017-09-19 | Rituximab | N | N | 260027902 | CYTARABINE INTRATHECAL |
| 260008432 | 260005651 | 1.82 | 71.3 | Disease modification (D) | null | 2014-10-17 | Rituximab | N | null | 260027902 | PEMBROLIZUMAB |
| 260008433 | 260005651 | null | 104 | Palliative (P) | null | 2016-05-09 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE | null | null | 260027902 | ETOPOSIDE |
| 260008434 | 260005652 | 1.85 | 78 | Curative (C) | 2013-11-11 | 2013-11-17 | Rituximab | 2 | N | 260027912 | RITUXIMAB |
| 260008435 | 260005653 | 1.81 | 63 | Adjuvant (A) | 2019-02-22 | 2019-02-22 | Cisplatin + Etoposide (5 day) | 01 | N | 260027913 | FCR |
| 260008436 | 260005653 | null | 65.4 | Disease modification (D) | 2013-08-27 | 2013-08-28 | null | 02 | N | 260027913 | ABVD |
| 260008437 | 260005654 | 1.67 | null | Disease modification (D) | 2013-09-04 | 2013-09-08 | Rituximab | N | N | 260027915 | EOX |
| 260008438 | 260005655 | 1.52 | 81 | Palliative (P) | 2016-03-29 | 2016-04-11 | Azacitidine | 02 | N | 260027917 | TRIAL |
| 260008439 | 260005656 | null | 64.3 | Curative (C) | null | 2017-02-24 | Rituximab | null | null | 260027919 | ECX |
| 260008440 | 260005656 | null | 76 | Curative (C) | 2016-06-12 | 2016-06-23 | RCEOP | N | N | 260027919 | RITUXIMAB |
| 260008441 | 260005656 | null | 76 | Disease modification (D) | 2018-09-10 | 2018-09-11 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 2 | N | 260027919 | RITUXIMAB |
| 260008442 | 260005657 | 1.83 | 56.3 | Adjuvant (A) | 2017-06-12 | 2017-06-18 | BLEOMYCIN + VINCRISTINE | 02 | Y | 260027924 | CARBOPLATIN + ETOPOSIDE |
| 260008443 | 260005658 | 1.78 | 90.999 | Palliative (P) | 2016-06-25 | 2016-06-26 | Rituximab (Maintenance) | N | N | 260027925 | AZACITIDINE |
| 260008444 | 260011920 | 1.67 | 0 | Curative (C) | 2016-02-04 | 2016-02-26 | CHLORAMBUCIL + RITUXIMAB | N | N | 260027931 | REMODL TRIAL |
| 260008445 | 260005659 | 1.64 | 85.6 | Curative (C) | 2015-06-10 | 2015-07-06 | Bendamustine +/- Prednisolone | N | N | 260027932 | RITUXIMAB |
| 260008446 | 260005660 | null | 77.7 | Palliative (P) | null | 2017-10-16 | Fluorouracil + Folinic Acid Weekly | N | N | 260027933 | IVE-R |
| 260008447 | 260005660 | 1.9 | 74 | null | 2013-07-31 | 2013-07-31 | Fluorouracil + Folinic Acid Weekly | N | N | 260027933 | CHLORAMBUCIL + RITUXIMAB |
| 260008448 | 260015521 | 1.69 | 64 | Palliative (P) | 2015-01-11 | 2015-01-17 | Trial Unspecified | N | N | 260027935 | RCEOP |
| 260008449 | 260005661 | 1.64 | null | Palliative (P) | 2016-01-16 | 2016-01-17 | Rituximab (Maintenance) | Y | N | 260027936 | RITUXIMAB |
| 260008450 | 260005661 | null | 116.7 | Curative (C) | 2018-02-08 | 2018-03-06 | CHOP - 21 days | N | N | 260027936 | RITUXIMAB |
| 260008451 | 260005662 | 1.69 | 103 | null | null | 2015-11-02 | Rituximab (Maintenance) | 02 | null | 260027940 | CISPLATIN + ETOPOSIDE |
| 260008452 | 260005662 | 1.74 | 67.5 | Palliative (P) | null | 2015-12-11 | Carboplatin + Etoposide IV 3 day | null | null | 260027940 | DOXORUBICIN |
| 260008453 | 260005662 | 1.85 | null | Curative (C) | 2014-12-17 | 2014-12-19 | Rituximab | 02 | N | 260027940 | ESHAP |
| 260008454 | 260005663 | 1.66 | 78.4 | Disease modification (D) | 2014-04-02 | 2014-04-02 | Rituximab | 02 | N | 260027949 | FCR |
| 260008455 | 260005663 | 1.78 | 68 | Curative (C) | 2013-11-22 | 2013-11-24 | Cisplatin + Etoposide (5 day) | 2 | n | 260027949 | CAPECITABINE + OXALIPLATIN |
| 260008456 | 260005663 | null | 90 | Curative (C) | null | 2014-10-01 | CYCLOPHOSPHAMIDE + FILGRASTIM | null | null | 260027949 | ECX |
| 260008457 | 260005664 | 1.72 | 95 | Curative (C) | 2014-05-13 | 2014-05-13 | Rituximab (Maintenance) | 02 | N | 260027956 | RITUXIMAB |
| 260008458 | 260011925 | 1.79 | null | Curative (C) | 2017-05-14 | 2017-05-13 | null | 02 | N | 260027957 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 260008459 | 260005665 | 1.83 | 90.3 | Disease modification (D) | 2016-12-03 | 2016-12-07 | null | N | N | 260027959 | BENDAMUSTINE |
| 260008460 | 260005666 | null | 94.9 | null | null | 2015-03-14 | R Chlorambucil | null | null | 260027960 | RITUXIMAB |
| 260008461 | 260005667 | 1.7 | 74 | Adjuvant (A) | 2013-07-11 | 2013-07-14 | ABVD | 2 | N | 260027962 | CHLORAMBUCIL + RITUXIMAB |
| 260008462 | 260005668 | 1.55 | 98 | Curative (C) | 2015-05-17 | 2015-05-18 | Rituximab | 99 | null | 260027964 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260008463 | 260011926 | 1.73 | 96.4 | Curative (C) | 2014-03-26 | 2014-04-01 | Hydroxycarbamide | 01 | N | 260027965 | PACIFICO TRIAL |
| 260008464 | 260011926 | null | null | Disease modification (D) | 2017-06-02 | 2017-09-30 | ECX | N | N | 260027965 | CARBOPLATIN + ETOPOSIDE |
| 260008465 | 260011926 | 1.85 | 61.2 | null | null | 2018-02-09 | PEMBROLIZUMAB | null | null | 260027965 | DOCETAXEL |
| 260008466 | 260005669 | 1.54 | 59.8 | Disease modification (D) | 2016-09-05 | 2016-10-15 | RUXOLITINIB | N | N | 260027970 | BENDAMUSTINE |
| 260008467 | 260005670 | 1.59 | 63.6 | Palliative (P) | 2016-10-12 | 2016-10-15 | ESHAP | 2 | Y | 260027972 | PACIFICO TRIAL |
| 260008468 | 260005670 | 1.67 | null | Unknown (U) | 2013-05-20 | 2013-05-29 | Rituximab (Maintenance) | N | N | 260027972 | CHLORAMBUCIL |
| 260008469 | 260005670 | null | 104 | Not known (9) | null | 2015-05-30 | CISPLATIN + ETOPOSIDE | null | null | 260027972 | RITUXIMAB |
| 260008470 | 260005670 | null | 72.9 | Adjuvant (A) | 2014-04-05 | 2014-04-15 | Rituximab (INTRAVENOUS Maintenance) | N | N | 260027972 | CAPECITABINE |
| 260008471 | 260018372 | null | 87.6 | null | null | 2016-08-15 | Rituximab | null | null | 260027979 | RITUXIMAB |
| 260008472 | 260005671 | 1.62 | 70 | Curative (C) | 2017-08-07 | 2017-08-21 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 260027980 | RITUXIMAB |